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 Abstract 
    The goal of this research is producing antibiotic from two 
Actynomycites species  isolated from the high tolerant ecosystem, isolate from 
high salty soil and high alkaloid soil, used whey and yeast extract medium as a 
perfect medium to culturing (1% glucose, 1% trypton, 0.092% glycine, 0.004% 
HCl and 8.5 PH), perfect incubation circumstances are 30 C0 in 4 days, the 
infiltrate of crude antibiotic concentrate by using a rotary evaporator, then 
extract the antibiotic from concentrate infiltrate with ethanol: methanol: ethyl 
acetate methods ( 50:30:20 Vol), drying the extract at 30 C0 to dissolve both 
antibiotic in distilled water with three concentration ( 50, 75, 100 µg/ml) and 
disinfectant by 0.45 Millipore. 
Antibiotic activity from two isolates of Streptomyces sp.  were measured 
against positive and negative control bacteria (Escherichia coli, Bacillus 
subtilis, streptococcus pyogenes and staphylococcus aureus) by well diffusion 
method, the results show the antibiotic produced by isolating No. 2 active 
against E. coli, S. aureus and S. pyogenes  while the isolating No. 1 were active 
only against E. coli and no activity against gram positive bacteria. 
Extract component was separated with TLC technique (thin layer 
chromatography) by using silica gel 20*20cm with high polar mix (7 water: 5 
acetic acid: 3 biotanol vol.) according to relative factor Rf  for antibiotic, 
isolate No.1 give 0.6 Rf  for one antibiotic and isolate No.2  give 0.15 Rf  for two 
antibiotic against S. aureus  and the other one with 0.45 Rf  against E. coli and 
S. pyogenes, means these antibiotic has synergism activity. 
Introduction 
            Actinomycetes are positive to gram stain grow in aerobic condition and 
some obligate anaerobic, chemo-organic nutrition, some grow in extreme 
circumstances like acidophil or alkalophil [1]. 
Morphemically is varied between cocci like Micrococcus to branched 
mycelium hold long threads attached to long chains of spores [2]. 
Actinomycetes very important source of antibiotics which also produce 
secondary metabolism active against microorganism and as anticancer, 
antibiotic number produced by Actinomycetes reaches 2500 antibiotic, 73% of 
this antibiotic secreted by Streptomyces [3]. 
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Actinomycetes secondary metabolism not just briefing on antibiotic it’s also 
secreted enzyme like catalase, its mycelium are grounded and aero and its 
branched spores are fragmented tend to  form bulges, these spores vary in size 
with smooth and forked wall [2]. because of its ability to produce 73-75% of 
antibiotic chemicals compound so it’s important economically, its produced 
broad spectrum of antibiotic like glycosides, aminoglycosides, glycopeptides, 
betalactamase, peptides and tetracycline [3], and as increasing to antibiotic 
resistant pathogens there is necessary to developing and find new chemicals 
compounds may produce by un-isolated Streptomyces. 
 
Materials and methods  
Preparing mediums 
           Soluble whey –yeast extract medium prepared from 1% glucose, 1% 
trypton,0.092% glycine and 0.004% HCl, nutrient broth prepared by 
dissolving amount of broth in amount of distilled water according to 
instruction write on medium cane sterilized by autoclave. 
Bacterial activation  
            Streptomyces isolates was collected from an advanced biotechnology 
lab at Babylon university / college of science activated by culturing on casein-
starch agar medium incubate at 30 C0 for 14 days, then studying colony 
formation and diagnosis bacterial cell form to culturing Soluble whey –yeast 
extract medium (ISP1) in 30 C0 for 7 days, the solution was calibrated with 
McFarland3 tube. 
Antibiotic production and harvesting  
            Sterile implant medium (100 ml) was inoculate with antibiotic bacteria 
producer under study, three replicate for each isolate of bacteria antibiotic 
producer by adding 2 ml of bacteria (match to McFarland tube No. 3), 
incubate at 30 C0 for 5 days, then estimate activity using Whatman filtered 
paper No. 1 to filtering medium then 0.45 Millipore to sterile solution, 
antibiotic solution was concentrated by  rotary evaporator with 60 C0 
preparing to dissolve it with different types of solvents like ethyl acetate, 
ethanol and methanol  by adding 5 ml of solvent to 1 ml of concentrate 
antibiotic solution, more concentration of solution by evaporator to condense 
volume to 4 ml and then saved at 4 C0, by using agar well diffusion the results 
was read by measuring diameter of inhibition zone [4]. 
Then layer chromatography (TLC) 
            This method used to measure relative factor (Rf) and also for detecting 
purity of antibiotics, in this technique we used glass plates coated with silica 
gel after activating it ( activation is done with 120 C0 of heating for 1 hour), the 
mobile phase is biotanol: acetic acid: water (3:5:7) high polarity, loading 5 µl 
of partially purified antibiotic solution about 1cm far away from the edge of 
plate soaked in TLC jar that contain mobile phase then left for 2 hours, results 
showed as spots after exposing the plate to iodine vapor Rf measured by 
calculate : 
Journal of University of Babylon for Pure and Applied Sciences,Vol.(26), No.(7): 2018 
303 
 
   
                          
                       
 
 
 Results and discussion  
            Activity of Streptomyces sp.1 and Streptomyces sp.2 to produce 
Secondary metabolites  inhibit negative and positive gram bacterial growth 
was tested by inoculate bacteria in soluble whey-yeast extract medium under 
perfect circumstances (30C0, 4 days) then extract antibiotic and dissolved in 
high polarity mix ethanol :methanol :ethyl acetate (50:30:20) followed by 
drying and prepare three concentration ( 100, 75, 50 µg), results showed 
Streptomyces sp.1 have ability to inhibit E.coli while show no result of 
inhibition to gram positive pathogenic bacteria as shown in table (1-1),  same 
results showed of Streptomyces  isolated from soil samples from different 
localities of Punjab and Himachal Pradesh (India) but more effective against 
E.coli  and other pathogenes [5] . 
 
Streptomyces sp.2 showed ability to inhibit gram positive and negative 
pathogenic bacteria except Bacillus subtilis  as shown in table (2-1) and that’s 
match with results in actinomycetes isolated from nepal soil which showed no 
inhibition zone against Bacillus subtilis  in both primary and secondary 
metabolites[6], that’s mean Streptomyces sp.2 have broad inhibition ability 
while antibiotic extracted from Streptomyces sp.1 effect only negative 
bacteria, antibiotics extracted from different bacteria its ability to inhibit is 
varying to inhibit positive and negative bacteria Consistent with what came 
with[7] they found 17 from 50 Actynomycites  isolates have vary ability to 
inhibit gram positive and negative pathogens, some inhibit both (- and + gram 
bacteria) and some ( - or + bacteria), also local research showed the same, 
that’s Actynomycites varying its inhibition ability to (- and + gram bacteria in 
adding to produce secondary metabolites inhibit fungi and anticancer 
materials in vevo[8] [9]. 
Table (1-1): Antibiotic activity for partial purified extract of 
Streptomyces sp.1 
          
Antibiotic          
Concentration 
 
 
Pathogens  
 Inhibition 
zone 
(melemeter) 
 
100 µg/ml 75 µg/ml 50µg/ml 
E. coli 18 14 11 
B. subtilis 0 0 0 
S. pyogenes 0 0 0 
S. aureus 0 0 0 
control 0 0 0 
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Table (2-1): Antibiotic activity for partial purified extract of 
Streptomyces sp.2 
 
         Antibiotic           
Concentration 
 
 
Pathogens  
 Inhibition 
zone 
(melemeter) 
 
100 µg/ml 75 µg/ml 50 µg/ml 
E. coli 16 13 10 
B. subtilis 0 0 0 
S. pyogenes 12 10 0 
S. aureus 13 12 10 
control 0 0 0 
 
Component of two antibiotics from both isolates was separated by TLC 
technique by using silica gel 20*20cm with biotanol:acetic aced:water (7:5:3) 
high polarity mix as mobile phase to measure Rf, results showed 0.6 Rf for 
Streptomyces sp.1 while Streptomyces sp.2 showed relative factor 0.15 to S. 
aureus and the other antibiotic extract show 0.45 Rf to S. pyogenes and E. coli 
as shown in figure (1-1) and table (3-1). 
 
 
 
Figure (1-1): Thin layer chromatography  for antibiotic extracted from  
Streptomyces sp.1 & sp.2 
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Table (3-1):  Flow rate of Rf antibiotic extracted from  Streptomyces 
sp.1 & sp.2 
Partial purified 
antibiotic 
Relative factor 
(Rf) 
Polarity Inhibited 
pathogens  
from  
Streptomyces 
sp.1 
0.6 Moderate 
polar 
E. coli 
from  
Streptomyces 
sp.2 
0.15 
0.45 
High polarity 
Moderate 
polar 
S. aureus 
S. pyogenes 
E. coli 
 
Antibiotic produced by different microorganism have vary chemical 
compound depending on its pathway of metabolism also depend on 
microorganism, some of them has glycosidic some peptide some steroid or 
beta-lactam etc. and each one of these antibiotic from different 
microorganism have specific relative factor Rf , the higher polarity  much more 
closer to start line of TLC, which mean Rf lowest than 0.3 while nonpolar 
compounds are closer to the end line of TLC , Rf more than 0.7 [4]. 
Streptomyces sp.2 is the perfect source to produce active antibiotic 
against gram negative and positive pathogenic bacteria, needs more study to 
characterize these antibiotic and tested on other pathogenic bacteria.  
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